ISSN (Online: 2321-5518, Print:2348–2885)
IMPACT FACTOR: 1.73; IC VALUE: 6.14

IJTEMT

Dr. Peter Malo

Dr. Peter Malo

Curriculum Vitae

AWARDS: NATO International Award Scholarship, 1984
OWNER: BluDesygn-Consulting, LLC,
PO Box 315,
124 W Freistadt Rd,
Thiensville, WI
United States

RESEARCH EXPERIENCE (DISSERTATION & PROJECTS)

i. Doctoral dissertation:
College of Arts and Sciences, Economics School, Universiti Utara Malaysia, Sintok, Kedah. Supervisor: Professor Mohd. Zaini Abdul Karim.

Peter Malo, M.P.M, M.B.A., Ph.D., J.D.

ADMINISTRATIVE POSITIONS:

participant with the Council of north Central two-year colleges (cnctyc) 2010 Fall leadership academy. September, 2010.

participant with the Council of north Central two-year colleges (cnctyc) 2010 summer leadership academy. June, 2010.

participant, symposia in curriculum development for inquiry based learning, emory university. June, 2010.

Director, office for college accreditation and College laison to the higher learning commission. April 2010 to October 2010.

Program Team Leader for Daley College for the Hispanic-Strategic-Initiative, Quality Education for Minorities and the National Science Foundation. September 2009 to April 2010.

CHAIR, DEPARTMENT OF BIOLOGY, Richard J. Daley College, 7500 South Pulaski Road, Chicago, IL 60652. December 12, 2007 to August 18, 2010.

CurricuNet® Administrator, Richard J. Daley College. May 2009 to September 2010.

OWNER, BluDesygn-Consulting, LLC, PO Box 315, 124 W Freistadt Rd, Thiensville, WI 53092-9998, 847-915-5454, FAX: 262-242-1627. BluDesygn-Consulting.com, August 2012 to present.

FACULTY POSITIONS:

FULL-TIME, Tenured FacuLTY MEMBER, Department of Natural Sciences, Richard J. Daley College, 7500 South Pulaski Road, Chicago, IL 60652.  December 11, 2008 to July 27, 2012.

Full-time faculty member, Department of Natural Sciences, Richard J Daley College, 7500 South Pulaski Road, Chicago, IL 60652.   January 2005 to December 10, 2008.


FACULTY POSITIONS (Cont.)

ASSOCIATE PROFESSOR, Center for Professional Education, Lewis University, One University Parkway, Romeoville, IL  60446 October 2004 to May, 2005.

ASSOCIATE PROFESSOR, Division of Science and Health Careers, Oakton Community College, 1600 E. Golf Road, Des Plaines, IL 6016. September 2002 to August 2003.

ADJUNCT FACULTY MEMBER, Department of Science, Triton College, 2000 Fifth Avenue, River Grove, IL  60171. January 2002 to May 2003.

2002 nominee for Oakton Community College’s Excellence in Teaching Award

ADJUNCT FACULTY MEMBER, Division of Science and Health Careers, Oakton Community College, 1600 E. Golf Road, Des Plaines, IL 60016.
Teaching Responsibilities: Microbiology, Pharmacology, Anatomy and Physiology and General Biology courses.  January 1998 to present.

Member of Illinois Education Association and National Education Association

ADJUNCT RESEARCH ASSOCIATE PROFESSOR, Section of Environmental Medicine, Department of Medicine, School of Medicine, The University of Illinois at Chicago, Chicago, IL. October 1989 to December 1990. 
 
ADJUNCT FACULTY MEMBER, Department of Nursing, Kalamazoo Valley Community College, Kalamazoo, MI.  Introductory and Advanced Pharmacology. May 1981 to June 1982

ADJUNCT FACULTY MEMBER, Department of Biology, Quinebaug Valley Community College, Danielson, CT.  Anatomy and Physiology, Microbiology, Genetics and General Chemistry courses. January 1978 to May 1980

RESEARCH POSITIONS:

RESEARCH INVESTIGATOR PHARMACOLOGIST, Immunosciences Research, Abbott Laboratories, Abbott Park, IL 60064.
Responsibilities: Laboratory project manager responsible for in vitro/in vivo testing in support of the Zileuton Development Project
Teaching Responsibilities: The Chicago Medical School Scientific Research Mentoring Program.  May 1993 to August 1997. 

ASSOCIATE SENIOR INVESTIGATOR, Department of Pharmacology, SmithKline Beecham Laboratories, Philadelphia, PA.
Responsibilities: Associate laboratory manager responsible for in vitro/in vivo testing supporting the Asthma Drug Development Plan. June 1982 to May 1988


research POSITIONS (Cont.)

RESEARCH ASSISTANT, Department of Hypersensitivity Diseases Research, The Upjohn Company, Kalamazoo, MI.
Responsibilities: Determine the actions of new chemical entities on the cardiopulmonary system through the utilization of electronic monitoring, bioassay techniques, analytical biochemical methods and small animal surgery.  May 1980 to June 1982

STAFF RESEARCH ASSISTANT (BIOCHEMISTRY), Department of Respiratory Disease, St. Vincent Hospital, Worcester, MA, 01604.
Responsibilities: Design and institute new HPLC drug assays.
Start-up of small tissue culture laboratory for use in the study of neoplastic cells derived from lung. Assistant to local student intern research program between department and area universities and colleges. September 1977 to May 1980.

education:

B.S., 9/71-5/75 Biology, Department of Biology, Westfield State College, Westfield, MA             

Senior Thesis: "Fluctuations in Bacterial Eco-Systems Due to Industrial and Environmental Runoffs in a Segment of the Westfield River."

 

M.A., Cellular Biochemistry, Department of Biological Sciences, Western Michigan University, Kalamazoo, MI. 9/75-8/78        

Thesis: "The Effects of 17 ß Estradiol on the Atherosclerotic Causing Enzyme Xanthine Oxidase."
AWARDS:  Research Grant Award from the Graduate College, Western Michigan University. 1976-1977
Upjohn Co. Research Grant, 1976

Ph.D., Biochemical Pharmacology, Department of Bioscience and Biotechnology Drexel University, Philadelphia, PA. 9/82-3/88           
Dissertation: "The Effect of Various Eicosanoid Products of Arachidonic Acid on the Acyl CoA: Cholesterol Acyl Transferase Activity in Three Different Mammalian Cell Lines."
AWARDS: NATO International Award Scholarship, 1984


education (Cont.)

M.B.A., Keller Graduate School of Management, Chicago, Illinois.  9/93-6/96       

Degree concentration in Information Systems for spreadsheets and database management, decision support           systems and strategic and marketing information research and health industry analysis. 
Thesis project: Complete business plans for creation of a nutriceutical company, Advanced Nutritional Systems, Inc., including in-licensing and new product launch for nutritional supplement in HIV patients, Sustend/AD.

M.P.M., (Masters in Project Management), Keller Graduate School of Management, Chicago, Illinois. 9/93-6/95

Thesis project: Project manage a complete proposal, to refurbish, automate and bring on-line a 30,000 sq. foot factory in Malaysia.

Certified Master Project Manager™, American Academy of Project Management (AAPM), November 2012 to November 2014.

J.D., DePaul University College of Law, Chicago, Illinois. 8/97-6/00

Journal of Health Care Law: staff writer (1998-99), Editorial Board (1999-2000).
Peter Malo, Deciding Custody of Frozen Embryos: Many Eggs Are Frozen, But Who Is Chosen? 3 DePaul J. Health Care L., 307 (2000).  
Center for Science and Law, staff researcher (1998-1999).

Certification in Copyright Management and Leadership,
Center for Intellectual Property, University of Maryland University College, 2010.

Notary Public, State of Wisconsin, September 2012 to September 2016.

MEMBERSHIP IN SCIENTIFIC ORGANIZATIONS AND EDITORIAL BOARDS / REVIEWERSHIPS:

American Thoracic Society
New York Academy of Sciences
American Association for the Advancement of Science
American Chemical Society 
Society of Sigma Xi
1992 Who’s Who in Science and Engineering
Editorial Board, Journal of Methods and Findings in Experimental and Clinical Pharmacology
Reviewer for Canadian Journal of Physiology and Pharmacology
memberships/reviewerships (Cont.)

Reviewer for The Journal of Pharmacology and Experimental Therapeutics
Reviewer for Jones and Bartlett Learning, Pearson Publishers
Reviewer for John Wiley & Sons Publishers
Reviewer for Pearson Publishers

 

Consultant:

  • Consultant for resource and staff development at The Franklin Institute, Philadelphia, PA. 1985.
  • Consultant, Pearson Education and Learning Systems, 2010.

APPENDIX TO DR. MALO’S CURRICULUM VITA

bibliography-abstracts:

     1.   Malo, P.E., Wasserman, M.A. and Griffin, R.L.: Comparative Bronchopulmonary Effects of Beta-Adrenergic Receptor Modulation in Normal vs. Ascaris-Sensitive Dogs. Amer. Rev. Resp. Dis. 123:170 (1980).
2.   Malo, P.E., Wasserman, M.A. and Griffin, R.L.: The Effects of Lidocaine and Hexamethonium on Prostaglandin F2-alpha and Histamine-Induced Bronchoconstriction in Dogs.  The Pharmacologist 23:148 (1981).
3.   Malo, P.E., Wasserman, M.A. and Griffin, R.L.: The Effects of Intravenous and Aerosol Nifedipine on PGF2-alpha and Histamine-Induced Bronchoconstriction in Anesthetized Dogs. The FASEB Gordon Conference on Calcium and Smooth Muscle Function, July 1982.
4.   Malo, P.E. and Wasserman, M.A.: Inhibition of Thromboxane-Induced Bronchoconstriction by SK&F 88046 in Anesthetized Dogs. The Pharmacologist 25:102 (1983).
5.   Malo, P.E., Osborn, R.R. and Wasserman, M.A.: Further Evidence of Thromboxane-Mediated Bronchoconstriction by SK&F 88046. The Pharmacologist 26:156 (1984).
6.   Malo, P.E., Wasserman, M.A., Torphy, T.J., Parris, D.J. and Pfeiffer, D.F.: Further Characterization of Substance P on Guinea Pig Trachea. The Pharmacologist 27:256 (1985).
7.   Osborn, R.R., Torphy, T.J., Malo, P.E., Muccitelli, R.M., Tucker, S.S. and Wasserman, M.A.: Effects of SK&F 86002-A vs. Antigen and Arachidonic Acid (AA)-Induced Bronchoconstriction in Guinea Pigs. The Pharmacologist 28:142 (1986).
8.   Malo, P.E., Wasserman, M.A. and Pfeiffer, D.F.: Enhancement of Leukotriene D4-Induced Contraction of Isolated Guinea Pig Trachea by Platelet Activating Factor. Second International Conference on Platelet Activating Factor, Gatlinburg, TN, Oct. 1986.
9.   Schwartz, L., Malo, P.E., Sannes, P.L., Shatzman, A.R. and Bollen, A.: Recombinant Human Alpha-1-Antiprotease: Duration of Effectiveness in the Hamster Model of Elastase-Induced Emphysema. Amer. Rev. Resp. Dis. 135:153A (1987).


bibliography-abstracts: (Cont).

  10.   Hoffstein, S.T., Malo, P.E., Wheeldon, E.B., Sannes, P. and Bugelski, P.: Leukotriene D4  (LTD4) Induces Mucus Secretion from Goblet Cells in Guinea PIg Respiratory Epithelium. The FASEB J. 2:A410 (1988).
11.   Miyazawa, N., Theil, D., Su, Y., Malo, P., Camporsei, E., Watkins, W. and Moon, R.: The Role of Thromboxane in the Acute Lung Injury Induced by Microbubble Infusion. Summer 1988 Meeting of the American Society of Anesthesiologists.
12.   Malo, P.E., Wiley, Y.D., Shaughnessy, T.K., Bell, R.L., Summers, J.B., Brooks, D.W. and Carter, G.W.: Inhibition of Antigen-Induced Contractions of Guinea Pig Tracheal Strips (GPTS) By Lipoxygenase (5-LO) Inhibitors. Amer. Rev. Resp. Dis. 139:A92 (1989).
13.   Carter, G.W., Young, P.R., Albert, D., Bouska, J., Dyer, R.D., Malo, P.E., Bell, R.L., Summers, J.B., Brooks, D.W., Rubin, P. and Kesterson, J.: A-64077, A New Potent Orally Active Inhibitor of 5-Lipoxygenase (5-LO).  Third Interscience World Conference on Inflammation, Monte Carlo, March 1989.
14.   Brooks, D.W., Summers, J.B., Gunn, B.P., Martin, J.G., Martin, M.B., Mazdiyasni, H., Holms, J.H., Stewart, A.O., Moore, J.L., Young, P.R., Albert, D.H., Bouska, J.B., Malo, P.E., Dyer, R.D., Bell, R.L., Rubin, P., Kesterson, J. and Carter, G.W.: The Discovery of A-64077, A Clinical Candidate for Treating Diseases Involving Leukotriene Mediators. The 1989 International Chemical Congress of the Pacific Basin Societies, Dec 1989.
15.   Summers, J.B., Brooks, D., Gunn, B.P., Young, P., Albert, D., Bouska, J., Dyer, R., Malo, P., Bell, R., Rubin, P., Kesterson, J. and Carter, G.: A64077- A New Potent Orally Active Inhibitor of Leukotriene Biosynthesis.  FASEB Gordon Conference on Medicinal Chemistry, August 1989.
16.   Malo, P.E., Shaughnessy, T.K., Bell, R.L., Bouska, J., Hinz, W., Majest, S., Summers, J.B., Brooks, D.W. and Carter, G.W. The Effect of 5-Lipoxygenase Inhibition on Arachidonic Acid-Induced (AAI) Bronchoconstriction in the Anesthetized Guinea Pig.  The Pharmacologist 31: 172 (1989).
17.   Bell, R.L., Young, P., Malo, P.E., Bouska, J.B., Albert, D.H., Dyer, R.D., Basha, A., Bhatia, P.A., Shaughnessy, T., Roberts, E.M., Majest, S.M., Kurth, C., Brooks, D.W. and Carter, G.W.  Abbott-65260 Is An Effective, Orally Active 5-Lipoxygenase Inhibitor.  International Prostaglandin Meeting, Florence, Italy, May 1990.
18.   Malo, P.E., Shaughnessy, T.K., Bell, R.L., Summers, J.B., Brooks, D.W. and Carter, G.W.  The Effect of 5-Lipoxygenase Inhibition on Antigen-Induced (AAI) Bronchoconstriction in the Anesthetized Guinea Pig.  Symposium on New Drugs for Asthma, Satellite of XIth IUPHAR Meeting, Davos, Switzerland, 10-11 July 1990.


bibliography-abstracts: (Cont).

  19.   Carter, G.W., Young, P.R., Albert, D., Bouska, J., Dyer, R.D., Malo, P.E., Bell, R.L., Summers, J.B., Brooks, D.W., Rubin, P., Kesterson, J.  Development of A-64077, A Promising Agent For The Treatment Of Leukotriene-Mediated Diseases.  International Prostaglandin Meeting, Florence, Italy, May 1990.
20.   Bell, R., Abraham, W., Young, P., Lanni, C., Malo, P., Bouska, J., Hinz, W., Kurth, C., Majest, S., Otis, E., Roberts, E., Shaughnessy, T., Wilcox, D., Wiley, Y., Summers, J., Rubin, P., Brooks, D. and Carter, G.  Zileuton and A-69412: Two Inhibitors of Leukotriene Biosynthesis.  XIth Washington International Spring Symposium:  Prostaglandins, Leukotrienes and Lipoxins '91, Washington, D.C., May 1991.
21.   Wilcox, D., Malo, P., Young, P., Lanni, C., Kurth, C., Wiley, Y., Bell, R., Brooks, D.W. and Carter, G.: The Effect of Eicosanoid Inhibition in a Polyacrylamide Gel (PAG)-Induced Granuloma in Mice.  FASEB J. 6:663 (1992)
22.   Malo, P.E., Bell, R.L., Bouska, J., Brooks, D.W. and Carter, G.W.: The Use of 3-Substituted Furan N-Hydroxyureas as Effective and Novel 5-Lipoxygenase (5-LO) Inhibitors By Aerosol Administration in Antigen-Induced
           Bronchoconstriction in Anesthetized Guinea Pigs.  Amer. Rev. Respir. Dis. 145: A286 (1992).
23.   Malo, P.E., Bell, R.L., Shaughnessy, T.K., Bouska, J., Stewart, A.O., Brooks, D.W. and Carter, G.W.: Pulmonary Pharmacology of A-78773, A New Potent Orally Active 5-Lipoxygenase (5-LO) Inhibitor.  8th International Conf. on Eicosanoids, Montreal, Canada July 1992.
24.   Malo, P.E., Bell, R.L., Namovic, M.T., Shaughnessy, T.K., Brooks, D.W. and Carter, G.W.:  The Use of Two Guinea Pig Pulmonary Models to Differentiate Leukotriene Inhibitors with Different Mechanisms of Action. Amer. Rev. Respir. Dis. 147: A447 (1993).
25.   Harris, R.R., Wilcox, D., Malo, P., Bell, R.L., Brooks, D.W. and Carter, G.: The Effect of A-79175, A 5-Lipoxygenase Inhibitor, on Polyacrylamide Gel (PAG)-Induced Inflammation in Mice.  International Association of Inflammation Societies World Congress Inflammation '93 Oct 10-15, 1993, Vienna, Austria.
26.   Bell, R.L., Bouska, J., Lanni, C., Malo, P., Stewart, A.O., Brooks, D.W. and Carter, G.W.: The Biochemistry and Pharmacology of Novel 5-Lipoxygenase Inhibitors.
3rd International Meeting on Lipid Mediators, Jerusalem, Israel, Nov 1993.


bibliography-abstracts: (Cont).

  27.   Bell, R.L., Bouska, J.B., Harris, R.R., Malo, P.E., Hulkower, K.I., Otis, E.R, Walsh, R.E., Goodfellow, C.L., Shaughnessy, T.K., Namovic, M.T., Wilcox, D.M., Grayson, G.R., Majest, S.M., Stewart, A., Brooks, D.W. and Carter, G.W.: Biochemical and Pharmacological Characterization of N-Hydroxyurea Containing 5-Lipoxygenase Inhibitors.  9th International Conference on Prostaglandins and Related Compounds, Florence, Italy, 6-10 June 1994.
28.   Stewart, A.O., Brooks, D.W., Basha, A., Bhatia, P., Ratajczyk, J.D., Craig, R.A., Harris, R.R., Bouska, J.B., Malo, P.E., Bell, R.L. and Carter, G.W.:  ABT-761, A New Second Generation Leukotriene Inhibitor. 208th ACS National Meeting, Washington, D.C., August 21-25 1994.  Abstract MEDI-123.
29.   Bhatia, P., Brooks, D.W., Stewart, A.O., Basha, A., Ratajczyk, J.D., Craig, R.A., Harris, R.R., Bouska, J.B., Malo, P.E., Bell, R.L. and Carter, G.W.: ABT-761, A Second Generation Leukotriene Inhibitor.  Abstracts of the 10th International Conference on Organic Synthesis (IUPAC), Bangalore, India, December 11-16 1994, p.206, Abstract P-FRI-6.
30.   Malo, P.E., Shaughnessy, T.K., Harris, R.R., Bell, R.L., Brooks, C.D.W. and Carter, G.W.: The Ability of 5-Lipoxygenase Inhibitors to Interrupt an On-Going Antigen-Induced Bronchoconstriction In Anesthetized Guinea Pigs (GP).  Amer. J. of Respir. Critical Care Med. 151: A376 (1995).
31.   Woods, K.W., Brooks, C.D.W., Maki, R.G., Rodriques, K.E., Bell, R.L., Lanni, C., Bouska, J.B., Malo, P.E. and Carter, G.W.  Discovery of the Leukotriene Biosynthesis Inhibitor, A-81834.  Abstracts of Papers of the American Chemical Society 209 (pt. 1) 183-MEDI, 1995.
32.   Bell, R.L., Namovic, M.N., Walsh, R.E., Harris, R.R., Shaughnessy, T.K., Malo, P.E., Brooks, C.D.W. and Carter, G.W.: Comparison of ABT-761 to Zileuton in Rodent Models of Bronchoconstriction and Lung Eosinophilia. Asthma 95, Theory to Treatment, pg. 46; July 15-17 1995, Chicago, IL.
33.   Brooks, C.D.W., Bell, R.L., Bhatia, P., Kolasa, T., Stewart, A., Woods, K., Bouska, J., Harris, R., Hulkower, K., Malo, P.E. and Carter, G.W.  Progress Toward the Next Generation of Leukotriene Biosynthesis Inhibitors. The 1995 International Chemical Congress of the Pacific Basin Societies, Honolulu, Hawaii, Dec, 1995.
34.   Malo, P.E., Rattin, A.J. and Wegner, C.D.: Development of Airway Hyperresponsiveness and Lung Eosinophilia. Amer. J. of Respir. Critical Care Med. 153: A625 (1996).
35.   Malo, P.E., Rattin, A.J., Shaughnessy, T.K., Komater, V.A., Namovic, M.T., Harris, R.R. and Wegner, C.D.: Spirometry, Leukotriene Production and Cell Influx in a Nonhuman Primate Model of Allergic Bronchoconstriction.     Amer. J. of Respir. Critical Care Med. 153: A220 (1996).


bibliography-abstracts: (Cont).

36.   Mussatto, D.J., Malo, P.E., Shaughnessy, T.K., Lubbers, N.L., Burke, S.E., Pollock, D.M., Opgenorth, T.J. and Wegner, C.D.: Endothelin Receptor Subtype Function in the Pulmonary Vasculature of Primates. Amer. J. of Respir. Critical Care Med. 153: A87 (1996).
37.   Shaughnessy, T.K., Wegner, C.D., Albert, D.H., Morgan, D. and Malo, P.E.: An In Vivo Model to Measure Nasal Resistance (NR) in the Guinea Pig (GP). Amer. J. of Respir. Critical Care Med. 153: A523 (1996).
38.   Albert, D.H., Tapang, P., Morgan, D.W., Curtin, M.L., Sheppard, G.S., Davidson, S.K., Malo, P.E., Wegner, C.D., Summers, J.B. and Carter, G.W. Effects of A-137491, A Highly Potent and Selective PAF Antagonist, on PAF and Antigen-Induced Increase in Nasal Vascular Permeability in Brown Norway Rats.  Amer. J. of Respir. Critical Care Med. 153: A525 (1996).
39.   Bell, R.L., Harris, R.R., Bouska, J.J., Hulkower, K.I., Moore, J., Bhatia, P., Malo, P.E., Kolasa, T., Brooks, C.D.W. and Carter, G.W.: The Discovery of A-93178, A Potent and Bioavailable Leukotriene Biosynthesis Inhibitor.  10th International Conference on Prostaglandins and Related Compounds, Vienna, Austria, Sept 22-27, 1996.
40.   Hascall, T., Kadze, R. and Malo, P.E.: The Effect of Parenchymal Capillary Bed Inflammation on Antigen-Induced Hyperreactivity and Cell Influx in Lungs of Actively Immunized Brown-Norway Rats. Summer Research Fellows Symposia, The Chicago Medical School, Finch University of Health Sciences, North Chicago, IL, Sept 26 1996.
41.   Kadze, R. and Malo, P.E.: The Use of Eosinophil Peroxidase (EPO) and Myeloperoxidase  (MPO) as Markers of Granulocyte Activation in the Bronchioalveolar Lavage (BAL) Fluid from Antigen-Sensitive Nonhuman Primates. Summer Research Fellows Symposia, The Chicago Medical School, Finch University of Health Sciences, North Chicago, IL, Sept 26 1996.
42.   Kang, C., Penney, A.D. and Malo, P.E.: Characterization of an Animal Model of Human Idiopathic Pulmonary Fibrosis. Summer Research Fellows Symposia, The Chicago Medical School, Finch University of Health Sciences, North Chicago, IL, Sept 26 1996.
43.   Malo, P.E., Rattin, A.J., Shaughnessy, T.K., Mollison, K., Morgan, D., Albert, D. and Wegner, C.D. : The Effect of Immunosuppressants in a Non-Human Primate Model of Allergic Bronchoconstriction and Cellular Inflammation.  1997 ALA/ATS International Conference, May 17-21, 1997, San Francisco, CA.
44.   Malo, P.E., Shaughnessy, T.K., Bell, R.L., Kolasa, T., Bouska, J.B., Brooks, C.D.W. and Carter, G.W. : The Activity of a 5-Lipoxygenase Activating Protein (FLAP) Inhibitors in a Guinea Pig Model of Allergen-Induced Bronchoconstriction.  1997 ALA/ATS International Conference, May 17-21, 1997, San Francisco, CA.


bibliography-abstracts: (Cont).

  45.   Brooks, C.D.W., Stewart, A.O., Kolasa, T., Basha, A., Bhatia, P., Ratajczyk, J., Craig, R., Gunn, D., Harris, R.R., Bouska, J.B., Malo, P.E., Bell, R.L. and Carter, G.W.: Design of Inhibitors of Leukotriene Biosynthesis and Their Therapeutic Potential.  Meeting of IUPAC Natural Products, July, 1996, Chicago, IL.
46.   Malo, P.E.: The Effectiveness of Blackboard Use in Student Retention and Understanding.  Using Technology in Education, Purdue University, and March 2006.
47.   Malo, P.E.: Understanding Academic Use of Intellectual Property: Copyright 101.
Illinois Community College Faculty Association Annual Meeting, October, 2006, Springfield, IL.
48.   Malo, P.E.: Impact of Globalization on College Science Education.  Eduventures Seminars, October 2006, Boston, MA.
49.   Malo, P.E.: Use of IPOD Technology as an Effective Tool to Improve Retention of Science Knowledge.  Campus Technology Seminars, August 3, 2007, Washington, D.C.
50.   Malo, P.E.: Distribution of Fast Food Restaurants and Correlation to African-American Populations in the City of Chicago.  Obesity as a World Wide Epidemic, March 2008, Oxford University, Oxford, England.        

 

 Bibliography-Manuscripts:

    1.   Wasserman, M.A., Griffin, R.L. and Malo, P.E.: Aerosol Administration for Specific Pharmacologic Activity on the Tracheobronchial Tree.  In Proceedings of the Symposium on Inhalation Toxicology and Technology, ed. BKE Leong, Ann Arbor Science Publisher, Inc., Ann Arbor, MI, 1981, pg. 247-261.
2.   Wasserman, M.A., Griffin, R.L. and Malo, P.E.: Comparative In Vitro Tracheal Relaxant Effects of Two Vasoactive Intestinal Peptides. In Vasoactive Intestinal Peptides, ed. SI Said, Raven Press, 1982, pg. 177-183.
3.   Malo, P.E., Wasserman, M.A. and Griffin, R.L.: The Effects of Lidocaine and Hexamethonium on Prostaglandin F2-alpha and Histamine-Induced Bronchoconstriction in Normal and Ascaris-Sensitive Dogs. Drug Dev. Res. 2:567-576 (1982).
4.   Malo, P.E., Wasserman, M.A. and Griffin, R.L.: The Effects of Intravenous and Aerosol Nifedipine on PGF2-alpha and Histamine-Induced Bronchoconstriction in Anesthetized Dogs. J. Pharm. Exp. Therap. 221:410-415 (1982).
5.   Malo, P.E., Wasserman, M.A. and Griffin, R.L.: The Effects of Alpha-Adrenergic Receptor Modulation in the Airways of Normal and Ascaris-Sensitive Dogs. Eur. J. Pharm. 86:27-34 (1982).
6.   Malo, P.E., Wasserman, M.A., Leong, B.K.J., Powell, D.J. and Griffin, R.L.: Increases in Canine Pharmacologic Bronchoconstriction by Chronic Sulfur Dioxide Inhalation. Prostaglandins 25:179-192 (1983).
7.   Malo, P.E. and Griffin, R.L.: The Effects of Lidocaine and Hexamethonium on PGF2-alpha and Histamine-Induced Bronchoconstriction in SO2 Hyperreactive Beagle Dogs. Drug Dev. Res. 3:59-66 (1983).


Bibliography-Manuscripts: (cont.)

8.   Malo, P.E., Wasserman, M.A. and Griffin, R.L.: Inhibition by Nifedipine and Verapamil of an Ascaris  Antigen-Induced Bronchoconstriction in Beagle Dogs. Eur. J. Pharm. 92:69-77 (1983). 
9.   Wasserman, M.A. and Malo, P.E.: SK&F 88046: Inhibition of Thromboxane-Induced Bronchoconstriction in Anesthetized Dogs. Prostaglandins, Leukotrienes and Medicine 17:213-222 (1985).    
10.   Malo, P.E., Wasserman, M.A. and Osborn, R.R.: Evidence for a Thromboxane Antagonist in Selected In Vitro and In Vivo Systems.  In Ettore Majorana International Life Sciences Series, Drugs Affecting Leukotrienes and Other Eicosanoid Pathways, pg. 249-263, (1985).
11.   Malo, P.E., Wasserman, M.A., Pfeiffer, D.F. and Parris, D.J.: Antagonism of Pharmacological and Antigen-Induced Contraction of Guinea Pig Trachea by Auranofin. J. Allergy  Clin. Immun. 77:371-379 (1986).
12.   Malo, P.E. and Wasserman, M.A.: The Effect of Calcium Antagonists in Inhibition of Guinea Pig Tracheal Microvascular Permeability. Prostaglandins 32:221-233 (1986).                
13.   Malo, P.E., Wasserman, M.A., Pfeiffer, D.F. and Parris, D.J.: Further Characterization of Substance P on Guinea Pig Trachea. J. Pharm. Exp. Thera. 237:782-786 (1986).
14.   Malo, P.E., Wasserman, M.A., Muccitelli, R. and Tucker, S.: SK&F 93944: In Vitro and In Vivo Evidence for a Potent Nonsedating Antihistamine. Methods and Findings 8:461-468 (1986).
15.   Malo, P.E., Wasserman, M.A. and Pfeiffer, D.F.: Platelet Activating Factor-Induced Potentiation of a Leukotriene D4 Contraction in Isolated Guinea Pig Trachea. Prostaglandins 33:209-226 (1987).
16.   Malo, P.E. : Chronological Relationships between Mediator Release and Changes in Airway Dynamics during an Ascaris Response in Sensitive Cynomolgus Monkeys. Prost. Leuko. Ess. Fatty Acids 35: 105-111 (1989).
17.   Malo, P.E.: 5-HETE-Induced Potentiation of a Leukotriene D4 Contraction in Isolated Guinea PIg Trachea. Prostaglandins 37: 539-551 (1989).
18.  Hoffstein, S.T., Malo, P.E., Wheeldon, E.B. and Bugelski, P. : The In Vivo Effect of SK&F 104353-Z2 on LTD4-Induced Mucus Secretion and Corresponding Bronchoconstriction in the Anesthetized Guinea Pig. _ Exp. Lung Res. 16 : 711-725 (1990).      
19.   Bell, R.L., Bouska, J., Young, P.R., Lanni, C., Machinist, J., Malo, P.E., Summers, J.B., Brooks, D.W. and Carter, G.W.: The Properties of A-69412: A Small Hydrophilic 5-lipoxygenase Inhibitor. Agents and Actions 38 (3-4):178-187 (1993).
20.   Bell, R.L., Lanni, C., Malo, P. E., Brooks, D.W., Stewart, A.O., Hansen, R., Rubin, P., and Carter, G.W.: Preclinical and Clinical Activity of Zileuton and A-78773. In Immunosuppressive and Anti-inflammatory Drugs, Vol 696 of The Annals of The New York Academy of Sciences, pp. 205-215, 1993.
21.   Malo, P.E., Bell, R., Shaughnessy, T.K., Bouska, J., Summers, J.B., Brooks, D.W. and Carter, G.W.: The 5-Lipoxygenase Inhibitory Activity of Zileuton in In Vitro and In Vivo Models of Antigen-Induced Airway Anaphylaxis. Pulmonary  Pharmacology 7:73-79 (1994).   


Bibliography-Manuscripts: (cont.)

  22.   Bell, R.L., Bouska, J., Lanni, C., Malo, P., Stewart, A., Brooks, D.W. and Carter, G.W.: The Biochemistry and Pharmacology of Novel 5-Lipoxygenase Inhibitors, in Lipid Mediators in Health and Disease , Freund Publishing, pgs. 89-96, 1994.
23.   Bell, R.L., Bouska, J., Malo, P., Harris, R.R., Lanni, C., Otis, E.R., Stewart, A.O., Brooks, D.W. and Carter, G.W.: Optimization of the Potency and Duration of Action of N-hydroxyurea 5-Lipoxygenase Inhibitors. J. Pharm. Exp. Therap. 272:724-731 (1995).
24.   Brooks, C.D.W., Stewart, A.O., Basha, A., Bhatia, P., Ratajczyk, J.D., Martin, J.G., Craig, R.A., Kolasa, T.J., Bouska, J.B., Lanni, C., Harris, R.R., Malo, P.E., Carter, G.W. and Bell, R.L.: ABT-761, R(+)N-3-[5-(4-Fluorophenylmethyl)-2-thienyl]-1-methyl-2-propynyl-N-hydroxyurea, a Second Generation 5-Lipoxygenase Inhibitor. J. Medicinal Chemistry 38:4768-4775 (1995).

  • Bell, R.L., Harris, R.R., Malo, P.E., Bouska, J.B., Shaughnessy, T.K., Hulkower, K.I., Brooks, C.D.W. and Carter, G.W.: ABT-761 Attenuates Bronchoconstriction and Pulmonary Inflammation in Rodents. J. Pharm. Exp. Therap. 280:1366-1373 (1997).
  • Albert, D.H., Malo, P.E., Tapang, P., Shaughnessy, T.K., Morgan, D.W., Wagner, C.D., Curtin, M.L., Sheppard, G.S., Xu, L., Davidsen, S.K., Summers, J.B. and Carter, G.W.: The Role of Platelet-Activating Factor (PAF) and the Efficacy of ABT-491, a Highly Potent and Selective PAF Antagonist, in Experimental Allergic Rhinitis.  J. Pharm. Exp. Therap. 284:83-88, 1998.
  • Brooks, C.D.W., Stewart, A.O., Kolasa, T., Anwer, Basha, Bhatia, P., Ratajczyk, J.D., Craig, R.A., Gunn, D., Harris, R.R., Bouska, J.B., Malo, P.E., Bell, R.L. and Carter, G.W.: Design of Inhibitors of Leukotriene Biosynthesis and Their Therapeutic Potential.  Pure & Appl. Chem., 70:2, 271-274, 1998.
  • Malo, P.E.: Deciding Custody of Frozen Embryos: Many are Called, but Few are Chosen. 3 DePaul J. Health Care L., 307, 332 (2000)
Submit Paper | Please Submit your Paper Here